The Omicron variant of the CCP (Chinese Communist Party) virus can best the antibodies from Pfizer’s COVID-19 vaccine, according to a newly released small study led by South African researchers.
Samples of plasma drawn from 12 people who received the Pfizer-BioNTech vaccine were tested as part of a rapid response to the variant, which recently emerged in Africa and has triggered travel bans across the world.
